Congress holds hearing on national drug shortage

WASHINGTON -- The House Oversight Subcommittee on Health Care will hold a hearing tomorrow morning to examine the causes behind the shortages of more than 200 older generic drugs that are usually sold at slim profit margins.

The shortages have caused patients to miss or delay chemotherapy, as well as to receive inferior antibiotics, anesthetics and intravenous nutrition, according to Dr. Scott Gottlieb, a resident fellow at the American Enterprise Institute.

Your comment is subject to the rules of our Posting Policy

This comment may appear on your public profile. Public Profile FAQ

We hope you've enjoyed your free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com